T1	Limited_variation	13 64	Epidermal growth factor receptor ( EGFR ) mutations
T2	Disease	68 108	non-small cell lung cancer ( NSCLC ) are
T3	Pharmacodynamic_phenotype	146 208	response to EGFR - tyrosine kinase inhibitors ( EGFR -TKIs ) .
R1	isAssociatedWith	Arg1:T1	Arg2:T2
R2	influences	Arg1:T1	Arg2:T3
R3	isAssociatedWith	Arg1:T2	Arg2:T1
R4	influences	Arg1:T2	Arg2:T3
R5	influences	Arg1:T3	Arg2:T1
R6	treats	Arg1:T3	Arg2:T2
